Search Results - "Inoue, Takako"

Refine Results
  1. 1

    Novel biomarkers for the management of chronic hepatitis B by Inoue, Takako, Tanaka, Yasuhito

    Published in Clinical and molecular hepatology (01-07-2020)
    “…Hepatitis B virus (HBV) cannot be eliminated completely from infected hepatocytes because of the presence of intrahepatic covalently closed circular DNA…”
    Get full text
    Journal Article Book Review
  2. 2

    The Role of Hepatitis B Core-Related Antigen by Inoue, Takako, Tanaka, Yasuhito

    Published in Genes (09-05-2019)
    “…Hepatitis B virus (HBV) cannot be completely eliminated from infected hepatocytes due to the existence of intrahepatic covalently closed circular DNA (cccDNA)…”
    Get full text
    Journal Article
  3. 3

    Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation by Inoue, Takako, Kusumoto, Shigeru, Iio, Etsuko, Ogawa, Shintaro, Suzuki, Takanori, Yagi, Shintaro, Kaneko, Atsushi, Matsuura, Kentaro, Aoyagi, Katsumi, Tanaka, Yasuhito

    Published in Journal of hepatology (01-08-2021)
    “…A fully automated, novel high-sensitivity hepatitis B core-related antigen assay (iTACT-HBcrAg) has been developed. We demonstrate the clinical utility of…”
    Get full text
    Journal Article
  4. 4

    Novel strategies for the early diagnosis of hepatitis B virus reactivation by Inoue, Takako, Matsui, Takeshi, Tanaka, Yasuhito

    Published in Hepatology research (01-10-2021)
    “…Hepatitis B virus (HBV) reactivation under systemic chemotherapy or immunosuppressive therapy is a serious complication among HBV‐resolved patients. Some…”
    Get full text
    Journal Article
  5. 5

    Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi by Baudi, Ian, Inoue, Takako, Tanaka, Yasuhito

    “…The hepatitis B virus (HBV) cannot be removed completely from infected hepatocytes, owing to the presence of intrahepatic covalently closed circular DNA…”
    Get full text
    Journal Article
  6. 6

    Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy by Inoue, Takako, Watanabe, Takehisa, Tanaka, Yasuhito

    Published in Clinical and molecular hepatology (01-10-2023)
    “…The current requirement for biomarkers to detect hepatitis B virus (HBV) infection is polarized. One is a fully-automated and highly sensitive measurement…”
    Get full text
    Journal Article Book Review
  7. 7

    Hepatitis B virus and its sexually transmitted infection - an update by Inoue, Takako, Tanaka, Yasuhito

    Published in Microbial cell (05-09-2016)
    “…About 5% of the world's population has chronic hepatitis B virus (HBV) infection, and nearly 25% of carriers develop chronic hepatitis, cirrhosis, and…”
    Get full text
    Journal Article
  8. 8

    Cross-Protection of Hepatitis B Vaccination among Different Genotypes by Inoue, Takako, Tanaka, Yasuhito

    Published in Vaccines (Basel) (16-08-2020)
    “…Hepatitis B (HB) vaccination is the most effective method for preventing HB virus (HBV) infection. Universal HB vaccination containing recombinant HB surface…”
    Get full text
    Journal Article
  9. 9

    Two Concepts of Hepatitis B Core-Related Antigen Assay: A Highly Sensitive and Rapid Assay or an Effective Tool for Widespread Screening by Inoue, Takako, Yagi, Shintaro, Tanaka, Yasuhito

    Published in Viruses (26-05-2024)
    “…Hepatitis B core-related antigen (HBcrAg) reflects the activity of intrahepatic covalently closed circular DNA. HBcrAg can be detected even in chronic…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA by Uchida, Junji, Kato, Kikuya, Kukita, Yoji, Kumagai, Toru, Nishino, Kazumi, Daga, Haruko, Nagatomo, Izumi, Inoue, Takako, Kimura, Madoka, Oba, Shigeyuki, Ito, Yuri, Takeda, Koji, Imamura, Fumio

    Published in Clinical chemistry (Baltimore, Md.) (01-09-2015)
    “…Genotyping of EGFR (epidermal growth factor receptor) mutations is indispensable for making therapeutic decisions regarding whether to use EGFR tyrosine kinase…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer by Imamura, Fumio, Uchida, Junji, Kukita, Yoji, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Oba, Shigeyuki, Kato, Kikuya

    Published in Lung cancer (Amsterdam, Netherlands) (01-04-2016)
    “…Highlights • EGFR ctDNA rapidly responded to an EGFR-TKI as a response predictor. • Transient ctDNA peaks of various EGFR mutants appeared during EGFR-TKI…”
    Get full text
    Journal Article
  14. 14

    Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B by Watanabe, Takehisa, Inoue, Takako, Tanaka, Yasuhito

    Published in Microorganisms (Basel) (02-10-2021)
    “…The hepatitis B core-related antigen (HBcrAg) is an unprecedented novel HBV biomarker that plays an essential role in reflecting covalently closed circular DNA…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment by Uchida, Junji, Imamura, Fumio, Kukita, Yoji, Oba, Shigeyuki, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Kato, Kikuya

    Published in Cancer science (01-03-2016)
    “…Circulating tumor DNA (ctDNA) is an emerging field of cancer research. For lung cancer, non‐invasive genotyping of EGFR is the foremost application. The…”
    Get full text
    Journal Article
  18. 18

    Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316) by Tachihara, Motoko, Negoro, Shunichi, Inoue, Takako, Tamiya, Motohiro, Akazawa, Yuki, Uenami, Takeshi, Urata, Yoshiko, Hattori, Yoshihiro, Hata, Akito, Katakami, Nobuyuki, Yokota, Soichiro

    Published in BMC cancer (03-10-2018)
    “…Immune checkpoint inhibitors (ICIs) have emerged as promising therapeutic agents in non-small cell lung cancer (NSCLC). However, the duration for which ICIs…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Manual route modification using an oblique method following automatic virtual bronchoscopic navigation by Inoue, Takako, Kawamura, Takahisa, Kunimasa, Kei, Tamiya, Motohiro, Kuhara, Hanako, Nishino, Kazumi, Odani, Satomi, Imamura, Fumio, Kumagai, Toru, Miyake, Kotaro

    Published in Medicine (Baltimore) (29-04-2022)
    “…Virtual automatic bronchoscopic navigation (VBN) systems to determine the route to peripheral pulmonary lesions (PPLs) in lung cancer can improve diagnostic…”
    Get full text
    Journal Article